Trial of Nivolumab as a Novel Neoadjuvant Pre-Surgical Therapy for Locally Advanced Oral Cavity Cancer

Condition:   Oral Cavity SCC
Intervention:   Drug: Nivolumab
Sponsors:   David Neskey;   Bristol-Myers Squibb
Not yet recruiting - verified January 2017

http://ift.tt/2jUJb82